Approval of zidovudine (AZT) for acquired immunodeficiency syndrome. A challenge to the medical and pharmaceutical communities

JAMA. 1987 Sep 18;258(11):1517.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Utilization
  • Humans
  • Thymidine / adverse effects
  • Thymidine / analogs & derivatives*
  • Thymidine / therapeutic use
  • United States
  • United States Food and Drug Administration
  • Zidovudine

Substances

  • Antiviral Agents
  • Zidovudine
  • Thymidine